埃弗罗利莫斯治疗增强了单细胞衍生的树突细胞中抑制性免疫检查点分子的表达
Bahar Naseri1, Amirhossein Mardi1, Arezou Khosrojerdi2
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
对树突细胞 (DCs) 的Everolimus治疗增加了免疫检查点基因和改变了细胞表面标记物. 这表明,Everolimus可能会在DC中诱导耐受性状态,影响免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 树突细胞 (DCs) 是关键的抗原呈现细胞,连接先天性和适应性免疫.
- 电流调整是各种疾病的新兴治疗策略.
- 一种mTOR抑制剂Everolimus在移植中用于抑制免疫功能.
研究的目的:
- 研究Everolimus对单细胞衍生树突细胞 (mo-DCs) 成熟的影响.
- 评估Everolimus对mo-DCs免疫检查点基因表达的影响.
主要方法:
- 单细胞从PBMCs中分离出来,并使用GM-CSF和IL-4分化为mo-DCs.
- 未成熟的DCs被用Everolimus治疗了24小时.
- 通过流细胞计分析了表型特征,并使用实时PCR量化了免疫检查点基因表达.
主要成果:
- 治疗Everolimus显著增加了HLA-DR表达和降低了CD11c表达在DCs.
- 在Everolimus治疗的DC中观察到免疫检查点分子 (CTLA-4,VISTA,PD-L1,BTLA) 的表达显著增加.
结论:
- 埃弗罗利莫斯向DCs,调节其表型和功能,使其达到部分耐受性状态.
- 需要进一步的研究,以充分阐明Everolimus对DC激活状态的确切影响.
更多相关视频
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
相关概念视频
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
